The cells of origin of oral cavity squamous cell carcinoma (OCSCC) are unknown. We used a cell lineage tracing approach (adult K14-CreER 
Introduction
Oral cavity squamous cell carcinoma (OCSCC) is one of the most common human cancers in the world, with 25 280 new cases diagnosed and 5470 deaths in the USA in 2011 (1). The two major etiological factors in OCSCC are tobacco and alcohol (2, 3) . The recurrence of this cancer and the development of metastases indicate that some cancer cells, possibly including cancer stem cells (SCs), are either inherently resistant or acquire resistance to cancer treatment (4, 5) . Cancer SCs have been identified as a potential contributor to head and neck malignancies (6) (7) (8) (9) (10) (11) . However, the cells of origin of OCSCC, i.e. the normal cells initially neoplastically transformed during carcinogenesis, are not known.
Both the tongue and the skin are composed of stratified, squamous epithelia (12, 13) . Studies on skin cancer in mice have shown that neoplastic transformation of different normal epidermal cell populations in the differentiation lineage hierarchy results in tumors with different degrees of malignancy (14) (15) (16) and that the transformation of epidermal SCs, not transient amplifying cells, results in SCC of the skin (17, 18) . SCs in normal mouse tongue epithelium have been identified in the basal layer, and in a manner similar to what occurs in the skin, the differentiating progeny of SCs move up to the surface of tongues and eventually are shed (13) . Here, we address whether the epithelial basal layer cells serve as the SCs in the normal oral cavity, and additionally we determine the cells of origin of OCSCC.
OCSCCs induced in mice by the carcinogen 4-nitroquinoline 1-oxide (4-NQO) added to the drinking water demonstrate similarities to human oral tumors in terms of their morphological, histopathological and molecular characteristics (19) (20) (21) . 4-NQO treatment causes the loss of p16, elevation of epidermal growth factor receptor protein levels in mouse tongue epithelia and the development of papillomas and OCSCCs in mouse tongues (20) . Here, we use an inducible cell lineage tracing approach to characterize the location and function of epithelial SCs in the normal tongue and in oral cancer in mice induced by 4-NQO.
Materials and methods
Tamoxifen treatment and β-galactosidase assays for K14-CreER TAM ; ROSA26 mice K14-CreER TAM (Cat# 56822) double-positive transgenic mice and ROSA26 floxed STOP-LacZ double-positive transgenic mice (Cat# 003474), purchased from the Jackson Laboratory (Bar Harbor, ME), were bred to obtain K14-CreER TAM ; ROSA26 mice. The K14-CreER TAM ; ROSA26 mice received tamoxifen treatment (4 mg/mouse/day) by intraperitoneal injections on two consecutive days. At various time points (n = 2 per time point) after tamoxifen treatment, mouse ears and tongues were harvested for β-glactosidase activity assays (X-gal staining). The details are described in the Supplementary data, available at Carcinogenesis Online. The care and use of animals in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of Weill Cornell Medical College.
Carcinogenesis in the oral cavity induced by the carcinogen 4-NQO, tissue dissection and immunostaining
Four weeks after tamoxifen injection, K14-CreER TAM ; ROSA26 mice (~10 week old) were treated with vehicle as a negative control (n = 20) or 100 μg/ ml 4-NQO (Sigma, St Louis, MO) (n = 40) for 10 weeks, as described previously (19, 20) , and mouse ears and tongues were harvested when visible tumors developed after the termination of the 4-NQO treatment. Also, mouse ears and tongues (n = 3 per treatment and per time point) were harvested at various time points during the 4-NQO treatment. The tongues of mice were dissected immediately after cervical dislocation and gross lesions were identified and photographed. The histological diagnosis of squamous neoplasia was performed by a board certified pathologist (T.S.) on hematoxylin and eosin (H&E)-stained tissue samples that had been stained previously with X-gal (19, 20) . Paraffin-embedded sections from X-gal-stained mouse tongues were stained with a Ki67 antibody and an E-cadherin antibody (Supplementary data, available at Carcinogenesis Online).
Terminal deoxynucleotidyl transferase dUTP nick-end labeling assays
Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assays were performed on paraffin-embedded mouse tongue sections by using a TUNEL assay kit from Millipore, as described in Supplementary data, available at Carcinogenesis Online.
Statistical analyses
We performed statistical analyses by Student's t-test or one-way analysis of variance and subsequently the Bonferroni test or the Tukey test for multiple comparisons. Differences with a P < 0.05 (two-tailed test) were considered statistically significant.
Results

LacZ expression after tamoxifen treatment marks cells in normal tongue epithelium
We exposed K14-CreER TAM ; ROSA26 mice to a brief, 2 day tamoxifen treatment to mark permanently cells that express keratin 14 at the time of tamoxifen treatment and examined the X-gal(+) cells in tongues and in ears, which served as the positive control for X-gal staining (22) , at different time points thereafter. SCs in normal tongue epithelia express keratin 14 (13) , and this truncated keratin 14 promoter that drives the expression of CreER TAM is active only in the basal layer of normal tongue and skin stratified squamous epithelia (23 ( Figure 1A and B) . Tamoxifen treatment did not activate CreER TAM in all basal cells in K14-CreER TAM ; ROSA26 tongues because we did not observe all epithelial basal cells marked with X-gal, as expected from other published work using this approach (24) . In addition, higher tamoxifen concentrations resulted in a greater number of X-galstained cells in the basal layer (Supplementary Figure S1 , available at Carcinogenesis Online), indicating that the cells are equivalent and that the CreER TAM is not 100% efficient. We conclude that our cell lineage tracing approach marks a small proportion of normal basal cells in mouse tongues and that these marked cells are representative of the entire basal cell population. Because the marked, individual cells are sufficiently distant from each other, we can perform clonal analysis and follow the fate of individual, marked cells.
LacZ marks SCs in normal tongue epithelium
We postulated that if lacZ marks oral cavity epithelial SCs, which by definition means that the cells have a long life span, these cells and their progeny would be stained by X-gal both at early and later time points after tamoxifen treatment. On the contrary, if the lacZlabeled cells are not long-lived SCs, the X-gal-stained cells would only be detected at early time points after tamoxifen administration and these cells would disappear at later time points because they would differentiate and eventually die. We treated K14-CreER We then examined H&E-stained sections of paraffin-embedded X-gal-stained tissues (shown in Figure 1A ) to determine the locations of these X-gal(+) cells in tongue epithelia ( Figure 1B ). Scattered X-gal(+) cells were detected in the epithelia of tongues 1 and 2 days after tamoxifen treatment, with the majority of X-gal(+) cells residing in the basal layer (Figure 1B, 1 and 2 days), including some single basal cells (Supplementary Figure S2 , available at Carcinogenesis Online). We found that as early as 2 days after tamoxifen administration, X-gal(+) cells were present in the suprabasal layers, including some almost at the superficial layers ( Figure 1B , 2 days, white arrow). Since the life span of tongue epithelia suprabasal cells is short (~5-7 days) (13), we postulated that these X-gal(+) cells in suprabasal layers would move to the surface and would then be shed. One and 2 weeks after tamoxifen treatment, a greater number of X-gal(+) cells appeared in the suprabasal layers of the tongues, whereas a large number of X-gal(+) cells were also present in the basal layer ( Figure Figure S3 , available at Carcinogenesis Online). As a negative control, 12 weeks after oil (vehicle for tamoxifen) injection, we detected almost no X-gal(+) cells in the H&E-stained sections ( Figure 1B , 12 weeks, no Tam). We conclude that the X-gal(+) cells in the basal layer comprise some of the SCs in tongue epithelia, that these SCs have a long life span since we detect them at 12 week post-tamoxifen treatment and that these normal SCs produce X-gal(+) cells that differentiate and move to the surface as columns of cells directly above the basal SCs. Our data indicate that under normal conditions, SCs in the tongue divide asymmetrically to generate more differentiated daughter cells that move up through the epithelium as they differentiate (Supplementary Figure S2 , available at Carcinogenesis Online). We did not see a statistically significant expansion in size of these clonal X-gal(+) populations even after 50 weeks, indicating a lack of or very limited symmetric division of the lacZ-labeled basal cells along the basement membrane during normal tongue epithelial homeostasis (Supplementary Figure S4 , available at Carcinogenesis Online).
Carcinogen treatment results in fewer, larger X-gal(+)-stained regions in tongue epithelia
We next investigated whether a 10 week 4-NQO treatment affected the number and location of the X-gal(+) cells in the tongue epithelia. We treated K14-CreER TAM ; ROSA26 mice with 4-NQO starting 4 weeks after the 2 day tamoxifen treatment, a time when some of the basal cells were permanently marked with lacZ. We examined the X-gal(+) cells in tongues at different time points during and after the carcinogen treatment by whole-mount X-gal staining. One week of carcinogen treatment did not cause obvious quantitative changes in the distribution and sizes of X-gal(+) cell populations ( Figure 2A , 1 week, Con, 4-NQO; Figure 2Ci and Cii). Two weeks of 4-NQO treatment did not affect the numbers of X-gal(+) cell populations on the tongue dorsal surface (Figure 2Ci ), but did increase the sizes of some X-gal(+) areas on the tongue dorsal surface by 2-fold (P < 0.05) (Figure 2Cii ). However, starting at 6 weeks of carcinogen treatment, 4-NQO-treated tongues displayed an ~10-fold decrease in the number of X-gal(+) cell populations on the tongue dorsal surface, as compared We conclude that 4-NQO caused a decrease in the total number of X-gal(+) clonal cell populations and an increase in the sizes of X-gal(+) cell populations.
We also examined H&E-stained sections from these 4-NQOtreated tongues ( Figure 2B ). Compared with control tongues, 1 and 2 weeks of carcinogen treatment did not cause obvious changes in the distribution and sizes of X-gal(+) regions ( Figure 2B, 1 (marked with an asterisk), P < 0.01 (marked with two asterisks) and P < 0.001 (marked with three asterisks) after one-way analysis of variance and subsequently the Bonferroni test for multiple comparisons (two-tailed test) were considered to be statistically significant. cell populations were even larger ( Figure 2B, 46 weeks, 4-NQO) . Thus, a 10 week 4-NQO treatment resulted in fewer X-gal(+) clonal cell populations and some of the X-gal(+) clonal cell populations dramatically increased in size. We interpret these data to indicate that some of the X-gal(+) basal SCs are killed by the 4-NQO treatment and other SCs divide symmetrically to maintain an adequate number of SCs in the basal layer. This interpretation is supported by our TUNEL assay data (Supplementary Figure S5 , available at Carcinogenesis Online). In control (not treated with 4-NQO) tongue epithelium, we detected apoptotic suprabasal layer cells but no or very few apoptotic basal layer cells (Supplementary Figure S5 , available at Carcinogenesis Online). On the contrary, tongue epithelia during 4-NQO treatment displayed a greater number of apoptotic cells in the suprabasal layers, and more importantly, many basal layer cells were also undergoing apoptosis (Supplementary Figure  S5 , available at Carcinogenesis Online). Even after the termination of 4-NQO treatment, tongue epithelia still showed a greater number of basal layer cells undergoing apoptosis than tongue epithelia not treated with carcinogen (Supplementary Figure S5 , available at Carcinogenesis Online), suggesting that 4-NQO had a long-term impact on some basal layer cells.
Carcinogen treatment causes proliferation of cells in tongue epithelia
Since we observed increases in the sizes of clonal X-gal(+) cell populations after 4-NQO treatment (Figure 2 ), we tested if the 4-NQO treatments affected the proliferation of tongue epithelial cells [both X-gal(+) and X-gal(−) cells] by immunostaining with an antibody to Ki67, a marker of cell proliferation (25) . We found that in the control (non-carcinogen treated) tongue epithelia, 24.7 ± 9% of the cells were Ki67 positive, and these cells were normal based on maturation without cytologic or architectural atypia (Supplementary Figure S6 , available at Carcinogenesis Online), and that 1 week of 4-NQO did not significantly change the Ki67 labeling index (30.2 ± 9%) ( Figure 2D ). However, a 10 week 4-NQO treatment resulted in an approximately 2-fold increase in the Ki67 labeling index (47.3 ± 12%) in tongue epithelia, almost all in the basal layer (Supplementary Figure S6 , available at Carcinogenesis Online and Figure 2D , P < 0.05). Even 36 weeks after the termination of the 10 week 4-NQO treatment (46 weeks after the start of 4-NQO), in regions without visible tumors, tongue epithelia showed a labeling index of 47.8 ± 14%, mainly in the basal layer, a significantly greater labeling index than that of tongues of control animals of the same age (P < 0.01) ( Figure 2D) . We conclude that a 10 week 4-NQO treatment induced an increase in basal cell proliferation for a long period after the end of the 4-NQO treatment. We observed no differences in Ki67 labeling between X-gal(+) and X-gal(−) cells (data not shown) in tongue epithelia from control or from 4-NQO-treated mice at various time points (data not shown), as would be expected since the basal X-gal(+) cells are representative of the SCs in tongue epithelia and basal X-gal(−) cells are also tongue epithelial SCs.
X-gal(+) cells are present in tongue papillomas
We next investigated whether X-gal(+) cells were present in tongue papillomas. We detected tongue papillomas between 15 and 36 weeks after the termination of the 10 week 4-NQO treatment (Figure 3Ai , arrows), consistent with our previous studies (19, 20) . Some papillomas from the 30 mice that we examined by whole-mount X-gal(+) staining exhibited X-gal(+) cells (data not shown), and we showed that there were X-gal(+) cells in papillomas (arrows) in the 4-NQOtreated tongues (Figure 3Aiii and Aiv). Immunostaining showed that dual X-gal(+)/Ki67 (+) cells were also present in tongue papillomas ( Figure 3B, arrow) , indicating that some X-gal(+) cells in papillomas were proliferating, as were a similar percentage of X-gal(−) cells (data not shown). These X-gal(+) cells in tongue papillomas must have originated from the basal X-gal(+) cells we observed prior to 4-NQO treatment ( Figure 1B) . We suggest that the papillomas arose from more than one basal SC since only some of the cells in the tumor are X-gal(+).
X-gal(+) cells are present in tongue invasive SCCs
We next assessed if X-gal(+) cells were present in the invasive SCC induced by 4-NQO (20) . Among 40 mice treated with 4-NQO, OCSCCs from 19 mice contained X-gal(+) cells ( Figure 4A, arrow) . These data indicate that X-gal(+) cells are present in the invasive SCC. We also detected dual-labeled X-gal(+)/Ki67(+) cells in tongue OCSCCs ( Figure 4B, arrow) , suggesting that these cells are proliferating, as were a similar percentage of X-gal(−) cells (data not shown). These X-gal(+) cells in OCSCCs must have originated from the basal X-gal(+) SCs we observed prior to 4-NQO treatment ( Figure 1B) , indicating that long-lived SCs become neoplastically transformed in the oral cavity. Indeed, these X-gal(+)/Ki67(+) cells were malignantly transformed cells, characterized by migration across the basement membrane, nuclear atypia and increased mitoses ( Figure 4B, arrow) . In addition, the X-gal(+) cells (circled) (Supplementary Figure S7B , available at Carcinogenesis Online) in a X-gal(+) dysplastic region connected to an invasive cell carcinoma exhibited lower E-cadherin protein levels than control epithelial cells (Supplementary Figure  S7A , available at Carcinogenesis Online). Since all of the OCSCCs we examined contained both X-gal(+) and X-gal(−) cells, the OCSCCs are polyclonal in that they originated from more than one basal SC.
Discussion
We used a cell lineage tracing approach to characterize the epithelial SCs in the normal tongue and in mouse papillomas and OCSCCs induced by 4-NQO. The OCSCCs induced in mice by 4-NQO show similarities to human oral tumors in terms of their morphological, histopathological and molecular characteristics (19) (20) (21) .
Normal tongue epithelia contain SCs that reside in the basal layer
A X-gal(+) basal cell and another X-gal(+) cell directly above it, presumably the progeny of the basal X-gal(+) cell (Supplementary Figure S2 , available at Carcinogenesis Online, 1 day), and the columns of X-gal(+) cells in tongue epithelia we observed, containing basal layer cells and their progeny in the suprabasal compartment ( Figure 1B, 4, 8 , and 12 weeks), suggest that under normal conditions, the basal SCs divide asymmetrically to produce daughter cells that differentiate and move to the epithelial surface directly above the SC. Our data are not consistent with the clonal 'epidermal proliferative unit' model of the skin epithelia in which a slow-cycling SC is at the center of each epidermal proliferative unit, and this SC produces an adjacent cluster of short lived, transit amplifying cells at the basal layer that divide several times and then move upward and differentiate (26) . By 4 weeks after tamoxifen treatment, we observed either just single X-gal(+) basal cells (Supplementary Figure S2 , available at Carcinogenesis Online, 4 weeks) or single cell width columns of X-gal(+) cells from the basal layer to the surface ( Figure 1B) . These X-gal(+) columns of cells did not generally expand horizontally over time after tamoxifen treatment in normal tongue epithelia for up to 50 weeks (Figure 2A and B, 46 weeks, Con). In addition, our TUNEL assays also showed no or very few basal cells under apoptosis under normal circumstances (Supplementary Figure S5 , available at Carcinogenesis Online). Our data suggest that all of the basal cells in tongue epithelia are SCs that directly produce differentiated progeny by asymmetric division to maintain homeostasis ( Figure 5 ).
Of note, we also observed fewer X-gal(+)-labeled cells at 4, 8 and 12 weeks than at 1 and 2 weeks after tamoxifen treatment ( Figure 1A ). Currently we do not have an explanation for these data. However, our major finding is that under normal circumstances, the X-gal(+) cells represent long-lived, basal cells in the tongue epithelia that maintain homeostasis even months after tamoxifen treatment.
Recent studies have shown that homeostasis of some cycling tissues, such as the murine interfollicular epidermis of the skin, is maintained by a population of SCs that follow a random fate and neutral drift dynamics (27, 28) . In this 'random fate' model, lineage tracing experiments would be expected to show a continual loss of clones and a progressive increase in sizes of neighboring clones over time, i.e. the proportion of clones of size n at time t will be the same as that of clones of size 2n at time 2t (27, 28) . However, over a long time period (e.g. 50 weeks after tamoxifen injection), we did not detect horizontal expansion of X-gal(+) clonal regions in the whole-mount X-gal staining in control tongues (Figure 2A , 46 weeks, Con; Supplementary Figure S4 , available at Carcinogenesis Online) or of the column-like X-gal(+) clonal cell clusters in control tongue epithelia ( Figure 2B , 46 weeks, Con; Figure 2Ciii ). Very few basal cells in the normal epithelium undergo random apoptosis (Supplementary Figure S5A , available at Carcinogenesis Online). Thus, we reason that unlike the SCs in the mouse interfollicle epidermis (27, 28) , the epithelial SCs in normal tongue epithelia do not often detach from the basal layer and eventually die; therefore, there is little or no need for compensation by the proliferation of neighboring SCs to maintain the SC pool in the basal layer and thus, little or no expansion of clonal sizes (in our study, the sizes of X-gal(+) cell populations, Figure 2 , panels A and B, 46 weeks, Con; Figure 2Cii, iii; Supplementary Figure S4 , available at Carcinogenesis Online). Therefore, our lineage tracing data in the normal tongue epithelium are not consistent with the scaling behavior expected by the 'random fate' model (28).
4-NQO treatment results in the expansion of the sizes of some X-gal(+) cell clones and a loss of other X-gal(+) cell clones
It has been reported that 4-NQO causes cell death and also neoplastic transformation of cultured oral keratinocytes (29) (30) (31) . We show here that 4-NQO treatment caused a decrease in the numbers of some X-gal(+) clonal cell populations ( Figure 2C ) concomitant with an expansion in sizes of some X-gal(+) clonal cell populations (Figure 2A-C) and an increase in cell proliferation ( Figure 2D ). Moreover, 4-NQO treatment resulted in increased apoptosis in basal cells over the long term (Supplementary Figure S5 , available at Carcinogenesis Online). Therefore, our data suggest that during and after 4-NQO treatment, some SCs die and that the surviving, neighboring basal SCs compensate for this 4-NQO-induced SC loss by symmetric SC self-renewal, resulting in the progressive expansion of some X-gal(+) clonal cell populations and the disappearance of others ( Figure 5 ). In addition, 4-NQO induces mutations in cells by forming DNA adducts (31, 32) , which may contribute to the increased cell proliferation by modifying cell cycle check points. Therefore, if mutations caused by 4-NQO provide some SCs with a proliferative advantage, these SCs would replace their neighboring SCs and we would see an expansion of some X-gal(+) clones after the end of 4-NQO treatment. This is in fact what we observe (Figure 2A and B, 46 weeks). Strikingly, after 4-NQO treatment, we detected some very large X-gal(+) clones (Figure 2A and B, 46 weeks). This SC clonal expansion can have dire consequences, as all of the X-gal(+) cells in these large clonal populations are likely derived from one SC (e.g. Figure 2A and B, 46 weeks, 4-NQO, arrows) and if, hypothetically, that SC has acquired an initial deleterious mutation, all of the SCs in the basal layer that are derived from this SC will also carry this deleterious mutation.
SCs in tongue epithelia are the cells of origin of mouse tongue cancers induced by 4-NQO
We observed X-gal(+) cells in 4-NQO-induced papillomas and in invasive OCSCCs, and some of these X-gal(+) cells were proliferating ( Figures 3B and 4B) . Previous in vitro studies showed that it takes about 10 passages for normal rat oral keratinocytes to be neoplastically transformed after 4-NQO treatment and that the ability of cells to proliferate is very important for this transformation (29) . Studies on cancers from other tissues, such as mouse skin, brain, intestine and blood, show that SCs are more likely to be the cells of origin of cancers in these tissues rather than the SC progeny that do not live long enough to accumulate the mutations leading to the required neoplastic transformation (17, 18, (33) (34) (35) . The data reported here show that the papillomas and OCSCCs most likely arise from the tongue epithelial basal SCs, although we cannot completely exclude the possibility of spontaneous transformation of suprabasal cells. The tumors also appear to be multiclonal in origin since we did not see any tumors (out of 40 mice examined) comprised completely of X-gal(+) cells. Our lineage tracing data demonstrate that all tongue epithelial basal cells are SCs. We observe a small percentage of the basal cells labeled with X-gal in tongues of mice not treated with 4-NQO, and we also observe a small percentage of cells in papillomas and in invasive OCSCCs labeled with X-gal. The lineage tracing data are most consistent with asymmetric division of the basal SCs in normal epithelia, but symmetric division of some SCs after treatment of the mice with 4-NQO (see model, Figure 5 ).
Supplementary material
Supplementary data can be found online at http://carcin.oxfordjournals.org/
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